SEC Filing Details

Document Details

Filing Date
Oct 10, 2018
Document Date
Oct 10, 2018
Form Description
Registration of up to an additional 20% of securities for any offering registered on an S-1
Filing Group
Registration Statements
Company
Allogene Therapeutics
Issuer
Allogene Therapeutics, Inc.